Arrowhead Pharmaceuticals
ARWR
#1980
Rank
HK$76.19 B
Marketcap
HK$551.08
Share price
2.83%
Change (1 day)
196.35%
Change (1 year)

Market capitalization of Arrowhead Pharmaceuticals (ARWR)

Market cap: HK$76.19 Billion

As of December 2025 Arrowhead Pharmaceuticals has a market cap of HK$76.19 Billion. This makes Arrowhead Pharmaceuticals the world's 1980th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Arrowhead Pharmaceuticals from 1997 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$76.19 B315.98%
2024HK$18.31 B-28.66%
2023HK$25.67 B-28.82%
2022HK$36.06 B-33.25%
2021HK$54.03 B-11.59%
2020HK$61.12 B22.37%
2019HK$49.94 B454.66%
2018HK$9.00 B318.58%
2017HK$2.15 B141.32%
2016HK$0.89 B-68.63%
2015HK$2.84 B-9.25%
2014HK$3.13 B-4.55%
2013HK$3.28 B1164.53%
2012HK$0.25 B-24.24%
2011HK$0.34 B-31.51%
2010HK$0.50 B93.83%
2009HK$0.25 B-15.47%
2008HK$0.30 B-73.25%
2007HK$1.14 B-2.15%
2006HK$1.16 B5.4%
2005HK$1.10 B133.49%
2004HK$0.47 B57780.64%
2003HK$0.81 M231.69%
2002HK$0.24 M-60%
2001HK$0.61 M-75.31%
2000HK$2.49 M28.22%
1999HK$1.94 M-4.52%
1998HK$2.04 M64.91%
1997HK$1.23 M

End of Day market cap according to different sources

On Dec 10th, 2025 the market cap of Arrowhead Pharmaceuticals was reported to be:

HK$72.78 Billion
by Nasdaq info icon info icon
HK$74.09 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Alnylam Pharmaceuticals
ALNY
HK$424.19 B 456.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
HK$23.17 B-69.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$28.04 B-63.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
HK$1.13 B-98.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$3.937 T 5,067.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
HK$90.08 B 18.24%๐Ÿ‡บ๐Ÿ‡ธ USA